MADISON, WI–(Marketwired – January 24, 2017) – Redox, the leading integration platform for digital healthcare applications, announced today that it has closed a $9 million Series B financing. RRE Ventures led the round with participation from existing investors .406 Ventures, HealthX Ventures, and Flybridge Capital Partners. Redox will use the new capital to accelerate its product roadmap along the way to building the industry standard platform for seamless interoperability between health technology developers and health systems.
Redox launched in 2014 to build a secure network of integrated healthcare applications and health systems through which any organization connected becomes functionally interoperable. The Redox network has grown more than tenfold in the past year and now processes nearly a million clinical messages per day.
“We founded Redox around the idea that a networked approach is the only scalable way to achieve the promise of full interoperability,” said Luke Bonney, CEO and co-founder of Redox. “We view it as our mission to help the industry break the habit of building point-to-point connections that are expensive, unreliable, and ultimately exacerbate the problem. Our interoperable network becomes more efficient with each node we add. While we support various healthcare data standardization initiatives, we don’t think our clients should have to wait for these new standards to mature when, today, Redox can unlock the potential that full interoperability brings.” Read the full story here.
;
